Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Widge, Alicia T.; Rouphael, Nadine; Jackson, Lisa A.; Anderson, Evan J.; Roberts, Paul C.; Makhene, Mamodikoe; Chappell, James D.; Denison, Mark R.; Stevens, Laura J.; Pruijssers, Andrea J.; McDermott, Adrian B.; Flach, Britta; Lin, Bob C.; Doria‐Rose, Nicole A.; O’Dell, Sijy; Schmidt, Stephen D.; Neuzil, Kathleen M.; Bennett, Hamilton; Leav, Brett; Makowski, Mat; Albert, Jim; Cross, Kaitlyn; Edara, Venkata Viswanadh; Floyd, Katharine; Suthar, Mehul S.; Buchanan, Wendy; Luke, Catherine J.; Ledgerwood, Julie E.; Mascola, John R.; Graham, Barney S.; Beigel, John H.

doi:10.1056/nejmc2032195

letterNew England Journal of MedicineDec 3, 2020GREEN OA

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

ATAlicia T. Widge NRNadine Rouphael LALisa A. Jackson EJEvan J. Anderson PCPaul C. Roberts

National Institute of Allergy and Infectious Diseases · Emory University · +6 more institutions

PubMed

Indexed incrossrefpubmed

Abstract

Immunogenicity and the mRNA-1273 SARS-CoV-2 Vaccine Thirty-four adults received two 100-μg injections of the mRNA-1273 SARS-CoV-2 vaccine, and serum anti–spike protein and neutralizing antibody tit...

Citation impact

827

total citations

FWCI: 19.48
Percentile: 100%
References: 4

Citations per year

Authors

31

Topics & keywords

Topics

Keywords

Immunogenicity
Messenger RNA
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology
Vaccination
Antibody
Neutralizing antibody
Coronavirus disease 2019 (COVID-19)

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.